mRNA vaccines can induce the expression of tumor-specific antigens by activating dendritic cells and triggering the activation and proliferation of CD8+ T cells, CD4+ T cells, and NK cells to achieve specific immune attacks against tumors [112,113,114]. This evidence concerns the gene CD8A and neoplasm.